The Biomarker and Cardiac Function in Sepsis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2008 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00800631
First received: December 1, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
  Purpose

The development and severity of sepsis induced myocardial dysfunction can be monitored from the serum biomarker.


Condition
Sepsis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Biomarker and Associated Cardiac Function in the Patients With Sepsis

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 150
Study Start Date: January 2008
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

sepsis

Criteria

Inclusion Criteria:

  • Sepsis patients with 2 of the followings when arrival ER and treated > 6 hours:

    • BT >38℃ or<36℃
    • HR >90/min
    • RR >20/min or PaCO2 < 32 mmHg
    • WBC count >12×109/L or <4×109/L or immature form >10%

Exclusion Criteria:

  • Age < 18
  • Major trauma patients
  • Pregnancy
  • Willing to do not aggressive treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00800631

Contacts
Contact: ChiungYuan Hsu, Mph 886-2-23123456 ext 65926 dtemer01@gmail.com

Locations
Taiwan
ER of National Taiwan Univeristy Hospital Recruiting
Taipei, Taiwan, 100
Contact: Chiung Yuan Hsu, Mph    886-2-23123456 ext 65926    dtemer01@gmail.com   
Sponsors and Collaborators
National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: Chiung-Yuan Hsu/ Attending VS of Emergency Department, National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00800631     History of Changes
Other Study ID Numbers: 200708002R
Study First Received: December 1, 2008
Last Updated: December 1, 2008
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Sepsis
Toxemia
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes

ClinicalTrials.gov processed this record on July 22, 2014